Anxiety Disorders market worldwide is projected to grow by US$1. 3 Billion, driven by a compounded growth of 2. 7%. Antidepressants, one of the segments analyzed and sized in this study, displays the potential to grow at over 3%.

New York, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Anxiety Disorders Industry" - https://www.reportlinker.com/p05818037/?utm_source=GNW
The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.6 Billion by the year 2025, Antidepressants will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 2.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$37.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Antidepressants will reach a market size of US$204.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.3% over the next couple of years and add approximately US$371.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Abbott Laboratories, Inc.; Allergan PLC; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Noven Pharmaceuticals, Inc.; Pfizer, Inc.; Shionogi & Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.


Read the full report: https://www.reportlinker.com/p05818037/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Anxiety Disorders Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Anxiety Disorders Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Anxiety Disorders Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Anxiety Disorders Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Antidepressants (Therapeutic Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Antidepressants (Therapeutic Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Antidepressants (Therapeutic Type) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Benzodiazepines (Therapeutic Type) Potential Growth
Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Benzodiazepines (Therapeutic Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Benzodiazepines (Therapeutic Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Other Therapeutic Types (Therapeutic Type) Geographic
Market Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Other Therapeutic Types (Therapeutic Type) Region
Wise Breakdown of Global Historic Demand in US$ Million: 2009
to 2017
Table 12: Other Therapeutic Types (Therapeutic Type) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Anxiety Disorders Market Share (in %) by Company: 2019 & 2025
Table 13: United States Anxiety Disorders Market Estimates and
Projections in US$ Million by Therapeutic Type: 2018 to 2025
Table 14: Anxiety Disorders Market in the United States by
Therapeutic Type: A Historic Review in US$ Million for
2009-2017
Table 15: United States Anxiety Disorders Market Share
Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
CANADA
Table 16: Canadian Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
Table 17: Canadian Anxiety Disorders Historic Market Review by
Therapeutic Type in US$ Million: 2009-2017
Table 18: Anxiety Disorders Market in Canada: Percentage Share
Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
JAPAN
Table 19: Japanese Market for Anxiety Disorders: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 20: Anxiety Disorders Market in Japan: Historic Sales
Analysis in US$ Million by Therapeutic Type for the Period
2009-2017
Table 21: Japanese Anxiety Disorders Market Share Analysis by
Therapeutic Type: 2009 VS 2019 VS 2025
CHINA
Table 22: Chinese Anxiety Disorders Market Growth Prospects in
US$ Million by Therapeutic Type for the Period 2018-2025
Table 23: Anxiety Disorders Historic Market Analysis in China
in US$ Million by Therapeutic Type: 2009-2017
Table 24: Chinese Anxiety Disorders Market by Therapeutic Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Anxiety Disorders Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 25: European Anxiety Disorders Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 26: Anxiety Disorders Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 27: European Anxiety Disorders Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 28: European Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018-2025
Table 29: Anxiety Disorders Market in Europe in US$ Million by
Therapeutic Type: A Historic Review for the Period 2009-2017
Table 30: European Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025
FRANCE
Table 31: Anxiety Disorders Market in France by Therapeutic
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 32: French Anxiety Disorders Historic Market Scenario in
US$ Million by Therapeutic Type: 2009-2017
Table 33: French Anxiety Disorders Market Share Analysis by
Therapeutic Type: 2009 VS 2019 VS 2025
GERMANY
Table 34: Anxiety Disorders Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 35: German Anxiety Disorders Historic Market Analysis in
US$ Million by Therapeutic Type: 2009-2017
Table 36: German Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025
ITALY
Table 37: Italian Anxiety Disorders Market Growth Prospects in
US$ Million by Therapeutic Type for the Period 2018-2025
Table 38: Anxiety Disorders Historic Market Analysis in Italy
in US$ Million by Therapeutic Type: 2009-2017
Table 39: Italian Anxiety Disorders Market by Therapeutic Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 40: United Kingdom Market for Anxiety Disorders: Annual
Sales Estimates and Projections in US$ Million by Therapeutic
Type for the Period 2018-2025
Table 41: Anxiety Disorders Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapeutic Type for
the Period 2009-2017
Table 42: United Kingdom Anxiety Disorders Market Share
Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
SPAIN
Table 43: Spanish Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
Table 44: Spanish Anxiety Disorders Historic Market Review by
Therapeutic Type in US$ Million: 2009-2017
Table 45: Anxiety Disorders Market in Spain: Percentage Share
Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
RUSSIA
Table 46: Russian Anxiety Disorders Market Estimates and
Projections in US$ Million by Therapeutic Type: 2018 to 2025
Table 47: Anxiety Disorders Market in Russia by Therapeutic
Type: A Historic Review in US$ Million for 2009-2017
Table 48: Russian Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 49: Rest of Europe Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018-2025
Table 50: Anxiety Disorders Market in Rest of Europe in US$
Million by Therapeutic Type: A Historic Review for the Period
2009-2017
Table 51: Rest of Europe Anxiety Disorders Market Share
Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 52: Asia-Pacific Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 53: Anxiety Disorders Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 54: Asia-Pacific Anxiety Disorders Market Share Analysis
by Region/Country: 2009 VS 2019 VS 2025
Table 55: Anxiety Disorders Market in Asia-Pacific by
Therapeutic Type: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 56: Asia-Pacific Anxiety Disorders Historic Market
Scenario in US$ Million by Therapeutic Type: 2009-2017
Table 57: Asia-Pacific Anxiety Disorders Market Share Analysis
by Therapeutic Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 58: Anxiety Disorders Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 59: Australian Anxiety Disorders Historic Market Analysis
in US$ Million by Therapeutic Type: 2009-2017
Table 60: Australian Anxiety Disorders Market Share Breakdown
by Therapeutic Type: 2009 VS 2019 VS 2025
INDIA
Table 61: Indian Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
Table 62: Indian Anxiety Disorders Historic Market Review by
Therapeutic Type in US$ Million: 2009-2017
Table 63: Anxiety Disorders Market in India: Percentage Share
Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025
SOUTH KOREA
Table 64: Anxiety Disorders Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 65: South Korean Anxiety Disorders Historic Market
Analysis in US$ Million by Therapeutic Type: 2009-2017
Table 66: Anxiety Disorders Market Share Distribution in South
Korea by Therapeutic Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 67: Rest of Asia-Pacific Market for Anxiety Disorders:
Annual Sales Estimates and Projections in US$ Million by
Therapeutic Type for the Period 2018-2025
Table 68: Anxiety Disorders Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Therapeutic Type for
the Period 2009-2017
Table 69: Rest of Asia-Pacific Anxiety Disorders Market Share
Analysis by Therapeutic Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 70: Latin American Anxiety Disorders Market Trends by
Region/Country in US$ Million: 2018-2025
Table 71: Anxiety Disorders Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 72: Latin American Anxiety Disorders Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 73: Latin American Anxiety Disorders Market Growth
Prospects in US$ Million by Therapeutic Type for the Period
2018-2025
Table 74: Anxiety Disorders Historic Market Analysis in Latin
America in US$ Million by Therapeutic Type: 2009-2017
Table 75: Latin American Anxiety Disorders Market by
Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019,
and 2025
ARGENTINA
Table 76: Argentinean Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018-2025
Table 77: Anxiety Disorders Market in Argentina in US$ Million
by Therapeutic Type: A Historic Review for the Period 2009-2017
Table 78: Argentinean Anxiety Disorders Market Share Breakdown
by Therapeutic Type: 2009 VS 2019 VS 2025
BRAZIL
Table 79: Anxiety Disorders Market in Brazil by Therapeutic
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 80: Brazilian Anxiety Disorders Historic Market Scenario
in US$ Million by Therapeutic Type: 2009-2017
Table 81: Brazilian Anxiety Disorders Market Share Analysis by
Therapeutic Type: 2009 VS 2019 VS 2025
MEXICO
Table 82: Anxiety Disorders Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 83: Mexican Anxiety Disorders Historic Market Analysis in
US$ Million by Therapeutic Type: 2009-2017
Table 84: Mexican Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 85: Rest of Latin America Anxiety Disorders Market
Estimates and Projections in US$ Million by Therapeutic Type:
2018 to 2025
Table 86: Anxiety Disorders Market in Rest of Latin America by
Therapeutic Type: A Historic Review in US$ Million for
2009-2017
Table 87: Rest of Latin America Anxiety Disorders Market Share
Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 88: The Middle East Anxiety Disorders Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 89: Anxiety Disorders Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 90: The Middle East Anxiety Disorders Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 91: The Middle East Anxiety Disorders Market Estimates
and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025
Table 92: The Middle East Anxiety Disorders Historic Market by
Therapeutic Type in US$ Million: 2009-2017
Table 93: Anxiety Disorders Market in the Middle East:
Percentage Share Breakdown of Sales by Therapeutic Type for
2009, 2019, and 2025
IRAN
Table 94: Iranian Market for Anxiety Disorders: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Type
for the Period 2018-2025
Table 95: Anxiety Disorders Market in Iran: Historic Sales
Analysis in US$ Million by Therapeutic Type for the Period
2009-2017
Table 96: Iranian Anxiety Disorders Market Share Analysis by
Therapeutic Type: 2009 VS 2019 VS 2025
ISRAEL
Table 97: Israeli Anxiety Disorders Market Estimates and
Forecasts in US$ Million by Therapeutic Type: 2018-2025
Table 98: Anxiety Disorders Market in Israel in US$ Million by
Therapeutic Type: A Historic Review for the Period 2009-2017
Table 99: Israeli Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 100: Saudi Arabian Anxiety Disorders Market Growth
Prospects in US$ Million by Therapeutic Type for the Period
2018-2025
Table 101: Anxiety Disorders Historic Market Analysis in Saudi
Arabia in US$ Million by Therapeutic Type: 2009-2017
Table 102: Saudi Arabian Anxiety Disorders Market by
Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019,
and 2025
UNITED ARAB EMIRATES
Table 103: Anxiety Disorders Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Therapeutic Type for the Period 2018-2025
Table 104: United Arab Emirates Anxiety Disorders Historic
Market Analysis in US$ Million by Therapeutic Type: 2009-2017
Table 105: Anxiety Disorders Market Share Distribution in
United Arab Emirates by Therapeutic Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 106: Anxiety Disorders Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutic Type for the Period 2018-2025
Table 107: Rest of Middle East Anxiety Disorders Historic
Market Analysis in US$ Million by Therapeutic Type: 2009-2017
Table 108: Rest of Middle East Anxiety Disorders Market Share
Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025
AFRICA
Table 109: African Anxiety Disorders Market Estimates and
Projections in US$ Million by Therapeutic Type: 2018 to 2025
Table 110: Anxiety Disorders Market in Africa by Therapeutic
Type: A Historic Review in US$ Million for 2009-2017
Table 111: African Anxiety Disorders Market Share Breakdown by
Therapeutic Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT LABORATORIES
ALLERGAN PLC
BRISTOL-MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVEN PHARMACEUTICALS, INC.
PFIZER, INC
SHIONOGI & CO., LTD.
SUMITOMO DAINIPPON PHARMA CO.

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818037/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.